A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer-Reference-Cited by-同舟云学术

A phase I–II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer

Published:2000-06 Issue:6 Volume:11 Page:721-728
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Brockstein B.,Haraf D.J.,Stenson K.,Sulzen L.,Witt M.E.,Weichselbaum R.W.,Vokes E.E.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/11/6/721/19478530/11-6-721.pdf

Reference36 articles.

1. Cancer statistics;Landis;CA Cancer J Clin,1998

2. Head and neck cancer;Vokes;N Engl J Med,1993

3. Chemoradiotherapy for head and neck cancer;Brockstein;Principles & Practice of Oncology Updates,1996

4. Meta-analysis head and neck squamous-cell carcinoma. What is the role of chemotherapy?;Bourhis;Hematol Oncol Clin North Am,1999

5. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer];Munro;Br J Cancer,1995

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria;International Journal of Radiation Oncology*Biology*Physics;2022-07

2. Investigation of the adsorption behavior of two anticancer drugs on the pristine and BN-doped graphdiyne nanosheet: A DFT-D3 perception;Diamond and Related Materials;2021-11

3. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative;Frontiers in Immunology;2020-10-26

4. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer;Radiation Oncology;2020-04-16

5. Locoregional Recurrent or Second Primary Head and Neck Cancer: Management Strategies and Challenges;American Society of Clinical Oncology Educational Book;2016-05